TaiwanJ Pharmaceuticals Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced operating loss was TWD 111.442 million compared to TWD 187.014 million a year ago. Net loss was TWD 238.201 million compared to TWD 186.035 million a year ago. Basic loss per share was TWD 3.56 compared to TWD 3.45 a year ago.